Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: Progression of tumorigenesis in a disorder associated with multiple benign lesions

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 4, 2011, Pages

  Almeida, Madson Q ^a   Harran, Michelle ^a   Bimpaki, Eirini I ^a   Hsiao, Hui Pin ^a   Horvath, Anelia ^a   Cheadle, Chris ^c   Watkins, Tonya ^c   Nesterova, Maria ^a   Stratakis, Constantine A ^b  

^a Pediatric Endocrinology Inter institute Training Program   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR; PROTEIN BCL 2; PROTEIN KINASE C; PROTEIN MYB; PROTEIN P53; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR E2F1;

ADRENAL CORTEX TUMOR; ADULT; ARTICLE; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME 20Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CUSHING SYNDROME; DISEASE ASSOCIATION; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE OVEREXPRESSION; GENETIC GAIN; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MACRONODULAR ADRENOCORTICAL HYPERPLASIA; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE LEVEL; TUMOR GENE; TUMOR VOLUME;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADULT; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; HYPERPLASIA; MALE; NEOPLASMS, MULTIPLE PRIMARY; SYSTEMS INTEGRATION; TUMOR BURDEN;

EID: 79953896631     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2420     Document Type: Article

References (47)

1. Lacroix A 2009 ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:245-259
2. Lacroix A, Bourdeau I, Lampron A, Mazzuco TL, Tremblay J, Hamet P 2010 Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clin Endocrinol (Oxf) 73: 1-15
3. Stratakis CA 2009 New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors. Mol Cell Endocrinol 300:152-157
4. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M 2003 Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273-285 (Pubitemid 37304697)
5. Findlay JC, Sheeler LR, Engeland WC, Aron DC 1993 Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab 76: 189-191 (Pubitemid 23027578)
6. Minami S, Sugihara H, Sato J, Tatsukuchi A, Sugisaki Y, Sasano H, Wakabayashi I 1996 ACTH independent Cushing's syndrome occurring in siblings. Clin Endocrinol (Oxf) 44:483-488 (Pubitemid 26142880)
7. Gagliardi L, Hotu C, Casey G, Braund WJ, Ling KH, Dodd T, Manavis J, Devitt PG, Cutfield R, Rudzki Z, Scott HS, Torpy DJ 2009 Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): Clinical studies of three kindreds. Clin Endocrinol (Oxf) 70:883-891
8. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J 2004 Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15:375-382 (Pubitemid 39223344)
9. Lacroix A, Ndiaye N, Tremblay J, Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22:75-110 (Pubitemid 32187804)
10. Kjellman M, Kallioniemi OP, Karhu R, Höög A, Farnebo LO, Auer G, Larsson C, BäckdahlM1996 Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res 56:4219-4223 (Pubitemid 26305019)
11. Sidhu S, Marsh DJ, Theodosopoulos G, Philips J, Bambach CP, Campbell P, Magarey CJ, Russell CF, Schulte KM, Röher HD, Del-bridge L, Robinson BG 2002 Comparative genomic hybridization analysis of adrenocortical tumors. J Clin Endocrinol Metab 87: 3467-3474 (Pubitemid 34816405)
12. Figueiredo BC, Stratakis CA, Sandrini R, DeLacerda L, Pianovsky MA, Giatzakis C, Young HM, Haddad BR 1999 Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab 84:1116-1121 (Pubitemid 29138252)
13. Zhao J, Speel EJ, Muletta-Feurer S, Rütimann K, Saremaslani P, Roth J, Heitz PU, Komminoth P 1999 Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis. Am J Pathol 155: 1039-1045 (Pubitemid 29488910)
14. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P 2000 Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28:145-152 (Pubitemid 30246992)
15. SzabóPM, Tamási V, Molnár V, Andrásfalvy M, Tömböl Z, Farkas R, Kövesdi K, Patócs A, Tóth M, Szalai C, Falus A, Rácz K, Igaz P 2010 Meta-analysis of adrenocortical tumour genomics data: Novel pathogenic pathways revealed. Oncogene 29:3163-3172
16. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X, Stratakis CA 2003 Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinaseAexpression and activity. Cancer Res 63:5308-5319 (Pubitemid 37139845)
17. Bourdeau I, Matyakhina L, Stergiopoulos SG, Sandrini F, Boikos S, StratakisCA2006 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 91:3626-3632 (Pubitemid 44402147)
18. Hsiao HP, Kirschner LS, Bourdeau I, Keil MF, Boikos SA, Verma S, Robinson-White AJ, Nesterova M, Lacroix A, Stratakis CA 2009 Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab 94:2930-2937
19. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA 2000 Mutations of the gene encoding the protein kinase A type I-βregulatory subunit in patients with the Carney complex. Nat Genet 26:89-92
20. Horvath A, Mathyakina L, Vong Q, Baxendale V, Pang AL, Chan WY, Stratakis CA 2006 Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation. J Clin Endocrinol Metab 91:584-596 (Pubitemid 43236930)
21. Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK, Stratakis CA 2004 Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 23:1575-1585 (Pubitemid 38406520)
22. Stratakis CA 2003 Genetics of adrenocortical tumors: Gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metab 14:404-410 (Pubitemid 37392212)
23. Papanicolaou DA, Yanovski JA, Cutler Jr. GB, Chrousos GP, Nieman LK 1998 A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 83:1163-1167 (Pubitemid 28496386)
24. Gomez MT, Malozowski S, Winterer J, Vamvakopoulos NC, Chrousos GP 1991 Urinary free cortisol values in normal children and adolescents. J Pediatr 118:256-258
25. Cheadle C, Vawter MP, Freed WJ, Becker KG 2003 Analysis of microarray data usingZscore transformation. JMolDiagn 5:73-81 (Pubitemid 36553428)
26. Almeida MQ, Muchow M, Boikos S, Bauer AJ, Griffin KJ, Tsang KM, Cheadle C, Watkins T, Wen F, Starost MF, Bossis I, Nesterova M,StratakisCA2010 Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53β/β or Rb1β/β backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling. Hum Mol Genet 19:1387-1398
27. Huang da W, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC, Lempicki RA 2007 DAVID bioinformatics resources: Expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35(Web Server issue):W169-W75
28. Huang da W, Sherman BT, Lempicki RA 2009 Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
29. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP 2005 Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550 (Pubitemid 41528093)
30. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2+-CT method. Methods 25:402-408 (Pubitemid 34164012)
31. Rohlff C, Clair T, Cho-Chung YS 1993 8-Cl-cAMP induces truncation and down-regulation of the RIβ-subunit and up-regulation of the RIIβ-subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J Biol Chem 268:5774-5782 (Pubitemid 23090906)
32. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scardino PT, Sander C, Sawyers CL, Gerald WL 2010 Integrative genomic profiling of human prostate cancer. Cancer Cell 18:11-22
33. Chitale D, Gong Y, Taylor BS, Broderick S, Brennan C, Somwar R, Golas B, Wang L, Motoi N, Szoke J, Reinersman JM, Major J, Sander C, Seshan VE, Zakowski MF, Rusch V, Pao W, Gerald W, LadanyiM 2009 An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene 28:2773-2783
34. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A,HawesAC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK 2008 Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075
35. Roskoski Jr. R 2007 Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 62:179-213 (Pubitemid 46679285)
36. Gesierich S, Berezovskiy I, Ryschich E, Zöller M 2006 Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res 66:7083-7094 (Pubitemid 44197685)
37. Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M, Lochnit G, Preissner KT, ZöllerM2010 Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosomeinduced endothelial cell activation. Cancer Res 70:1668-1678
38. Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B 1994 Clonal composition of human adrenocortical neoplasms. Cancer Res 54:4927-4932 (Pubitemid 24289423)
39. Cohen MM, Charrow J, Balkin NE, Harris CJ 1983 Partial trisomy 14 (q23 leads to qter) via segregation of a 14/X translocation. Am J Hum Genet 35:635-644 (Pubitemid 13007974)
40. Ou Z, Martin DM, Bedoyan JK, Cooper ML, Chinault AC, Stankiewicz P, Cheung SW 2008 Branchiootorenal syndrome and oculoauriculovertebral spectrum features associated with duplication of SIX1, SIX6, and OTX2 resulting from a complex chromosomal rearrangement. Am J Med Genet A 146A:2480-2489
41. Tominaga E, Tsuda H, Arao T, Nishimura S, Takano M, Kataoka F, Nomura H, Hirasawa A, Aoki D, Nishio K 2010 Amplification of GNAS may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancer. Gynecol Oncol 118:160-166
42. Hines WC, Bazarov AV, Mukhopadhyay R, Yaswen P 2010 BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas. PLoS One 5:e9738
43. Plevova P, Cerna D, Balcar A, Foretova L, Zapletalova J, Silhanova E, Curik R, Dvorackova J 2010 CCND1 and ZNF217 gene amplification is equally frequent in BRCA1 and BRCA2 associated and non-BRCA breast cancer. Neoplasma 57:325-332
44. Paquet-Fifield S, Schlüter H, Li A, Aitken T, Gangatirkar P, Blashki D, Koelmeyer R, Pouliot N, Palatsides M, Ellis S, Brouard N, Zannettino A, Saunders N, Thompson N, Li J, Kaur P 2009 A role for pericytes as microenvironmental regulators of human skin tissue regeneration. J Clin Invest 119:2795-2806
45. Gaujoux S, Tissier F, Groussin L, LibéR, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X, Bertherat J 2008 Wnt/β-catenin and 3,5-cyclic adenosine 5-monophosphate/protein kinase A signaling pathways alterations and somaticβ-catenin gene mutations in the progression of adrenocortical tumors. J Clin Endocrinol Metab 93:4135-4140
46. Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA, Bourdeau I 2008 Detection of somaticβ-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD). Clin Endocrinol (Oxf) 69:367-373
47. Iliopoulos D, Bimpaki EI, Nesterova M, Stratakis CA 2009 MicroRNA signature of primary pigmented nodular adrenocortical disease: Clinical correlations and regulation of Wnt signaling. Cancer Res 69:3278-3282